Dropdown

EE - Estonia
All companies
    All persons

      Search word:

      Field/EMTAK

      MEDFILES OÜ

      Media page and news feed
      ?
      ?
      profile visits
      1,123
      ?
      company tracker
      18
      This company's branding has already reached 1,123 peopleand his is followed by 18 Storybook users.On average, the company has been rated 4.5 points.but there is

      MEDFILES OÜ current status

      2184939_andmerobot_99391772_a_xl.jpg
      Andmerobot
      Did you notice typos in the article?

      Dropdown

      This company's branding has already reached 1,123 peopleand his is followed by 18 Storybook users.On average, the company has been rated 4.5 points.but there is no comment.

      Tegevusaruanne 2023

      Kontserni põhitegevusalaks on meditsiinialaste teadusuuringute korraldamine ja ravimite registreerimise ning ravimiohutusega seonduvate teenuste osutamine.

      Kontserni struktuur: Medfiles OÜ osanik on 100% Medfiles OY, mis omandati 2017 a. märtsis Tokyo börsil noteeritud ettevõtte WDB Holding Ltd poolt.

      Medfiles OÜl on kaks tütarettevõtet - Medfiles SIA Lätis (100%) ja Medfiles UAB Leedus (100%).

      2023. aastal jätkus Kontsernil koostöö erinevate ravimeid tootvate ja arendavate firmadega, kelle tellimusel korraldati kliiniliste uuringute läbiviimist ja osutati ravimite, meditsiiniseadmete, kosmeetikatoodete ja toidulisandite registreerimisega seotud teenuseid Baltimaades ning mujal Euroopas.

      Medfiles OÜ juhatusse kuulub antud momendil 1 liige, kelleks on Norifumi Ninokata. Tütarettevõtete juhatuses on järgmised liikmed: Medfiles SIA juhatuse liikmeteks on Norifumi Ninokata ja Santa Zeibote ning Medfiles UAB juhatuse liikmeks on Norifumi Ninokata.

      Dividende makstakse vastavalt osanike otsusele.

      Juhatuse liikmetele 2023 nagu ka 2022 tasu ei makstud. Muid olulisi soodustusi ei ole ette nähtud.

      2023. aasta Kontserni müügitulu on 1,17 miljonit eurot ning majandusaasta tulemuseks kujunes 72 881 eurot kasumit. 2023 aasta Kontserni müügitulu moodustas 2022. aasta tulust 109,16%.

      Peamised suhtarvud 2023. ja 2022. aasta kohta: 2023 2022

      Müügitulu (EUR) 1 168 445 1 070 365

      Tulu kasv (%) 9,16 17,36

      Ärikasumimäär (%) 5,85 10,18

      Puhaskasum (EUR) 72 881 108 939

      Kasumikasv (%) -33,10 91,67

      Puhasrentaablus (%) 6,24 10,18

      Lühiajaliste kohustuste 6,79 4,54 kattekordaja (kordades)

      Maksevalmiduse kordaja 4,64 2,86 (kordades)

      ROA (%) 10,90 17,17

      ROE (%) 12,74 21,83

      Suhtarvude arvutamisel kasutatud valemid:

      Tulu kasv (%) = (müügitulu 2023-müügitulu 2022)/ müügitulu 2022*100

      Ärikasumimäär (%) = ärikasum/ müügitulu*100

      Kasumi kasv (%) = (puhaskasum 2023-puhaskasum 2022/ puhaskasum 2022*100

      Puhasrentaablus (%) = puhaskasum/ müügitulu*100

      Lühiajaliste kohustuste kattekordaja (kordades) = käibevara/ lühiajalised kohustused

      Maksevalmiduse kordaja (kordades) = raha/ lühiajalised kohustused

      ROA (%) = puhaskasum/ varad kokku*100

      ROE (%) = puhaskasum/ omakapital*100

      Comments (0)

      Are you sure you want to delete this article?

      Dropdown

      all articles
      MEDFILES OÜ / Andmerobot

      How to get health claims approved in the eu/us

      Health claims are statements made on food or supplement labels that describe the relationship between a food component and improved health or reduced risk of di
      ssb.ee
      Health claims are statements made on food or supplement labels that describe the relationship between a food component and improved health or reduced risk of disease. These claims are heavily regulated to ensure consumer protection and scientific accuracy. The European Union and the United States have distinct regulatory frameworks for health claims. In the EU, the European Food Safety Authority (EFSA) is responsible for evaluating the scientific evidence behind health claims, while in the US, the Food and Drug Administration (FDA) oversees the approval process. Understanding these
      MEDFILES OÜ / Andmerobot

      Navigating clinical trials for medical devices

      Clinical trials are a critical phase in the development of medical devices, ensuring that new products are safe and effective for patient use. These trials prov
      ssb.ee
      Clinical trials are a critical phase in the development of medical devices, ensuring that new products are safe and effective for patient use. These trials provide the scientific evidence necessary to satisfy regulatory requirements and gain market approval. Unlike pharmaceutical trials, medical device trials often involve additional complexities such as device-operator interactions, varying patient anatomies, and the iterative nature of device development. Regulatory Framework for Medical Device Trials Regulatory bodies such as the FDA in the United States, EMA in Europe, and others
      MEDFILES OÜ / Andmerobot

      The future of algae-based foods in europe

      Algae, a diverse group of photosynthetic organisms, is emerging as a sustainable superfood. Rich in proteins, vitamins, minerals, and essential fatty acids, alg
      ssb.ee
      Algae, a diverse group of photosynthetic organisms, is emerging as a sustainable superfood. Rich in proteins, vitamins, minerals, and essential fatty acids, algae presents a promising alternative to traditional food sources. With the ability to grow in a variety of environments, algae's versatility makes it a valuable asset in the food industry. Europe has seen a growing interest in algae-based foods, with several startups and established companies exploring its potential. The market is still in its nascent stages, but with increasing awareness and demand, algae-based foods are poised for

      File a complaint

      Choose the comment attribute that you think it contains:

      False information
      Spam
      Hate speech
      Terrorism
      Other

      You want to report an inappropriate comment.

      Are you sure?

      Are you sure you want to delete this article?

      Loader

      Loader

      App Ad

      Scorestorybook Chrome extension

      The Storybook extension tells you which company's website you are currently on and how reliable that company is today. download extension

      See the background of the caller! Storybook App brings you direct contacts for 400,000 Estonian companies and individuals (managers, officials). The data is enriched with solvency and financial information.

      We value your privacy

      We use cookies to improve your browsing experience, provide personalized ads or content, and analyze our traffic. By clicking "allow all", you agree to our use of all cookies.